Transdermal Patches And Fevers

Links shared publicly online about this topic.

  • 2,016
    total visits

Transdermal Patches And Fevers

health.einnews.com

Transdermal Patches And Fevers

View full resource at health.einnews.com

Tags: Fever

  • Share

Most Recently Shared on May 26, 2009 at 3:37 pm By:

FDA Reminds the Public about the Potential for Life-Threatening Harm from Accidental Exposure to Fentanyl Transdermal Systems (“Patches”)

fda.gov — “FDA reminds patients, caregivers, and healthcare professionals of the importance of appropriate storage, use, application, and disposal of fentanyl patches (Duragesic and generic products) due to potential life-threatening harm from accidental exposure.View full resource at fda.gov

  • View Related
  • Share

Most Recently Shared on April 19, 2012 at 4:54 pm By:

RxEconsultRxEconsult. If you are in need of healthcare services or information, please visit RxEconsult. 

Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.

Dr. Ogbru has written several journal articles. In 1997, he shared an award from the American Journal of Pain Management for Outstanding Contribution to the Interdisciplinary Pain Management Literature. Over the last 12 years Dr. Ogbru has held several roles in the pharmaceutical industry, including Director of Global Medical Information and Communication." /> Ome Ogbru, PharmD Pharmacist, PharmD, Active Health Library, and Doctor

FDA Reminder about the Danger of Fentanyl Patches http://t.co/DZsxhYeF

3 weeks ago...

The Research Report: Slapping On a Skin Patch to Combat Hay Fever - WSJ.com

online.wsj.com — “Skin patches coated with allergens may be a more convenient and effective way to treat hay fever than current methods, according to a studyView full resource at online.wsj.com

  • View Related
  • Share

Most Recently Shared on January 31, 2012 at 6:46 am By:

The Research Report: Slapping On a Skin Patch to Combat Hay Fever - WSJ.com

online.wsj.com — “Skin patches coated with allergens may be a more convenient and effective way to treat hay fever than current methods, according to a studyView full resource at online.wsj.com

  • View Related
  • Share

Most Recently Shared on January 31, 2012 at 1:48 am By:

Bulletin

ashp.org — “BulletinView full resource at ashp.org

  • View Related
  • Share

Most Recently Shared on November 29, 2011 at 4:43 pm By:

Novartis files suit against Watson over generic Exelon

news-medical.net — “Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market rivastigmine transdermal system patches, 4.6 mg/24 hr and 9.5 mg/24 hr.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on November 11, 2011 at 5:17 am By:

Parkinsons_News News-Medical.Net Health News

Parkinson's Disease: Novartis files suit against Watson over generic Exelon: Watson Pharmaceuticals, Inc. today ... http://t.co/ldd6pUdi

6 months ago...

Medical News: Sumatripan Patch Fails to Win FDA Nod - in Neurology, Migraines from MedPage Today

medpagetoday.com — “The FDA has turned down a transdermal patch formulation of the migraine drug sumatriptan, citing safety, chemistry, and manufacturing issues, its developer said.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on September 1, 2011 at 9:18 pm By:

Medical News: Sumatripan Patch Fails to Win FDA Nod - in Neurology, Migraines from MedPage Today

medpagetoday.com — “The FDA has turned down a transdermal patch formulation of the migraine drug sumatriptan, citing safety, chemistry, and manufacturing issues, its developer said.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on August 31, 2011 at 1:44 pm By:

Medical News: Sumatripan Patch Fails to Win FDA Nod - in Neurology, Migraines from MedPage Today

medpagetoday.com — “The FDA has turned down a transdermal patch formulation of the migraine drug sumatriptan, citing safety, chemistry, and manufacturing issues, its developer said.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on August 31, 2011 at 1:41 pm By:

medpagetoday MedPage Today Health News

FDA turns down sumatriptan patch Zelrix for migraine: http://t.co/Y0w1dUb

8 months ago...

Discarded Drug Patches Dangerous to Children | Parents News Now, by Holly Lebowitz Rossi

parents.com — “Transdermal patches, which are prescribed to adults to deliver drugs through the skin, can pose serious danger to children if not disposed of properly,View full resource at parents.com

  • View Related
  • Share

Most Recently Shared on August 12, 2011 at 4:30 pm By:

Drug patches pose overlooked danger to kids - TODAY Health - TODAY.com

today.msnbc.msn.com — “An 8-month-old Maine boy who overdosed on a grandparent's used medication patch is prompting patient safety experts to warn caregivers about dangers to kids posed by growing numbers and types of transdermal medications. View full resource at today.msnbc.msn.com

  • View Related
  • Share

Most Recently Shared on August 12, 2011 at 2:33 pm By:

Neurology Article | Parkinson Disease

mdlinx.com — “Overnight switch from ropinirole to transdermal rotigotine patch in patients with Parkinson diseaseView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on August 12, 2011 at 12:02 am By:

MDLinx Sandeep Pulim MD Physician, Doctor, and Health Communicator

Overnight switch from ropinirole to transdermal rotigotine patch in patients with Parkinson disease: BMC ... http://bit.ly/ndVwDE #neuro

9 months ago...

Drug patches pose overlooked danger to kids - Health - Kids and parenting - msnbc.com

msnbc.msn.com — “An 8-month-old Maine boy who overdosed on a grandparent's used medication patch is prompting patient safety experts to warn caregivers about dangers to kids posed by growing numbers and types of transdermal medications. View full resource at msnbc.msn.com

  • View Related
  • Share

Most Recently Shared on August 11, 2011 at 12:52 pm By:

NuPathe to Present Additional Migraine Patch Data at International Headache Congress

marketwire.com — “CONSHOHOCKEN, PA--(Marketwire - Jun 23, 2011) - NuPathe Inc. (NASDAQ: PATH), a specialty pharmaceutical company focused on the development and commercialization of branded therapeutics for diseases of the central nervous system, including neurological and psychiatric disorders, today announced that additional safety data from a 12 month study of its transdermal...View full resource at marketwire.com

  • View Related
  • Share

Most Recently Shared on June 23, 2011 at 3:25 pm By:

Migraine_Wisdom Migraine OW OW Health

NuPathe to Present Additional Migraine Patch Data at International Headache Congress: Data Demonstrate a Low Ra... http://mwne.ws/iU4iVS

11 months ago...

Management of an Oral Ingestion of Transdermal Fentanyl Patches: A Case Report and Literature Review

hindawi.com — “Purpose. Fentanyl is available as a transdermal system for the treatment of chronic pain in opioid-tolerant patients; however, it carries a black box warning due to both the potency of the product and the potential for abuse. In this report, we describe a case of transbuccal and gastrointestinal ingestion of fentanyl patches and the management of such ingestion. Summary. A 32-year-old man was brought to the emergency department (ED) via emergency medical services for toxic ingestion and suicide View full resource at hindawi.com

  • View Related
  • Share

Most Recently Shared on May 13, 2011 at 2:35 pm By:

Health_SS Susan S Health Advocate

Management of an Oral Ingestion of Transdermal Fentanyl Patches: A Case Report and Literature… http://goo.gl/fb/iFWyP

12 months ago...

AAN: Skin Patch Induces MS Immune Tolerance (CME/CE) - QualityPoint Technologies

qualitypointtech.net — “HONOLULU (MedPage Today) -- Multiple sclerosis patients had fewer relapses and brain lesions when they were treated in a small trial with a transdermal patch that delivers myelin peptides.View full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on April 15, 2011 at 9:35 pm By:

MedicalFeed MedicalFeed Health News Feed

AAN: Skin Patch Induces MS Immune Tolerance (CME/CE): HONOLULU (MedPage Today) -- Multiple sclerosis patients had ... http://bit.ly/eeOLtk

1 year ago...

Advertisement